9 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 9 of 9 clinical reviews.
A breakdown of BPC-157's potential effects on adolescent development, covering bone growth, hormonal axes, neurological maturation, and why no pediatric safety data exist.
A guide to BPC-157's effects on tissue repair, inflammation, and age-related decline in adults 65 and older, including what animal data shows, what remains unknown in humans, and how to think about risk.
A guide covering what adolescents, parents, and school athletic staff need to know about BPC-157 use, its current regulatory status, proposed mechanisms, and practical implications for school performance and sports participation.
A guide covering BPC-157 use in adolescents ages 12 to 17, the evidence (and gaps) around this peptide, and how to safely transfer care to an adult provider without losing treatment continuity.
What is known about BPC-157 in older adults? Examine geriatric evidence gaps, animal pharmacokinetics, kidney-function assumptions, and interaction claims.
What parents and clinicians need to know about BPC-157 use in pediatric patients under age 12, including effects on cognition, physical activity, school performance, and safety signals in children.
A guide to BPC-157 use in pediatric patients under age 12 and the critical steps required when transitioning to adult care protocols, including safety data, regulatory status, and clinical decision frameworks.
A clinical review of BPC-157 (pentadecapeptide) use in pediatric patients under age 12, covering safety data, developmental concerns, regulatory status, and why no evidence supports its use in children.
What is missing from pediatric BPC-157 research, why adult or animal doses cannot answer child-specific questions, and what to do after an exposure.